Cervical cancer trials in Belarus

1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

  Where

  Minsk

  Age

  18 years to 75 years

  People

  120

  Run by

  N.N. Alexandrov National Cancer Centre

  See details and how to joinNCT07472153